ZNF747
gene geneOn this page
Also known as MGC2474
Summary
ZNF747 (zinc finger protein 747, HGNC:28350) is a protein-coding gene on chromosome 16p11.2, encoding Zinc finger protein 747 (Q9BV97).
Predicted to enable zinc ion binding activity. Predicted to be involved in regulation of DNA-templated transcription.
Source: NCBI Gene 65988 — RefSeq curated summary.
At a glance
- GWAS associations: 1
- Clinical variants (ClinVar): 37 total
- MANE Select transcript:
NM_001305018
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:28350 |
| Approved symbol | ZNF747 |
| Name | zinc finger protein 747 |
| Location | 16p11.2 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | MGC2474 |
| Ensembl gene | ENSG00000169955 |
| Ensembl biotype | protein_coding |
| Entrez | 65988 |
Gene structure
Transcript identifiers
Ensembl transcripts: 5 — 5 protein_coding
ENST00000252799, ENST00000395094, ENST00000568028, ENST00000693075, ENST00000937379
RefSeq mRNA: 4 — MANE Select: NM_001305018
NM_001305018, NM_001305019, NM_001305020, NM_023931
CCDS: CCDS10682, CCDS76855, CCDS76856, CCDS92140
Canonical transcript exons
ENST00000693075 — 3 exons
| Exon | Start | End |
|---|---|---|
| ENSE00003580086 | 30534197 | 30534310 |
| ENSE00003922767 | 30530367 | 30533151 |
| ENSE00003925643 | 30534451 | 30534858 |
Expression profiles
Bgee: expression breadth ubiquitous, 246 present calls, max score 94.48.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 4.6698 / max 36.8794, expressed in 1566 samples.
FANTOM5 promoters (2 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 157061 | 4.2368 | 1478 |
| 157062 | 0.4330 | 202 |
Top tissues by expression
280 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| olfactory bulb | UBERON:0002264 | 94.48 | silver quality |
| buccal mucosa cell | CL:0002336 | 91.62 | gold quality |
| diaphragm | UBERON:0001103 | 91.43 | gold quality |
| type B pancreatic cell | CL:0000169 | 91.37 | gold quality |
| tendon of biceps brachii | UBERON:0008188 | 91.32 | gold quality |
| medial globus pallidus | UBERON:0002477 | 89.97 | gold quality |
| globus pallidus | UBERON:0001875 | 86.67 | gold quality |
| secondary oocyte | CL:0000655 | 84.16 | gold quality |
| triceps brachii | UBERON:0001509 | 83.17 | gold quality |
| mucosa of urinary bladder | UBERON:0001259 | 83.13 | silver quality |
| gluteal muscle | UBERON:0002000 | 81.61 | gold quality |
| oviduct epithelium | UBERON:0004804 | 81.54 | gold quality |
| heart right ventricle | UBERON:0002080 | 81.18 | silver quality |
| oocyte | CL:0000023 | 80.25 | gold quality |
| gastrocnemius | UBERON:0001388 | 79.88 | gold quality |
| muscle of leg | UBERON:0001383 | 79.14 | gold quality |
| apex of heart | UBERON:0002098 | 79.05 | gold quality |
| lower esophagus muscularis layer | UBERON:0035833 | 78.91 | gold quality |
| lower esophagus | UBERON:0013473 | 78.86 | gold quality |
| parotid gland | UBERON:0001831 | 78.81 | silver quality |
| cardiac ventricle | UBERON:0002082 | 78.52 | gold quality |
| heart left ventricle | UBERON:0002084 | 78.52 | gold quality |
| muscle organ | UBERON:0001630 | 78.34 | gold quality |
| right lobe of liver | UBERON:0001114 | 78.33 | gold quality |
| esophagogastric junction muscularis propria | UBERON:0035841 | 78.28 | gold quality |
| popliteal artery | UBERON:0002250 | 78.19 | gold quality |
| tibial artery | UBERON:0007610 | 78.19 | gold quality |
| orbitofrontal cortex | UBERON:0004167 | 78.17 | gold quality |
| fallopian tube | UBERON:0003889 | 78.15 | gold quality |
| prefrontal cortex | UBERON:0000451 | 77.81 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 4.09 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
92 targeting ZNF747, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-3613-3P | 100.00 | 76.36 | 7965 |
| HSA-MIR-4510 | 100.00 | 66.60 | 2050 |
| HSA-MIR-6127 | 100.00 | 66.76 | 2188 |
| HSA-MIR-6129 | 100.00 | 66.46 | 2080 |
| HSA-MIR-6130 | 100.00 | 66.69 | 2012 |
| HSA-MIR-6133 | 100.00 | 66.48 | 2064 |
| HSA-MIR-371B-5P | 99.99 | 75.34 | 4759 |
| HSA-MIR-373-5P | 99.98 | 75.36 | 4753 |
| HSA-MIR-616-5P | 99.98 | 75.58 | 4775 |
| HSA-MIR-12136 | 99.98 | 72.81 | 5713 |
| HSA-MIR-548N | 99.98 | 71.94 | 4170 |
| HSA-MIR-1229-3P | 99.97 | 66.49 | 906 |
| HSA-MIR-4267 | 99.96 | 66.53 | 2368 |
| HSA-MIR-548AB | 99.95 | 71.31 | 3488 |
| HSA-MIR-559 | 99.95 | 72.28 | 3609 |
| HSA-MIR-548A-5P | 99.94 | 71.27 | 3482 |
| HSA-MIR-548AD-5P | 99.94 | 71.23 | 3502 |
| HSA-MIR-548AE-5P | 99.94 | 71.23 | 3502 |
| HSA-MIR-548AK | 99.94 | 71.24 | 3488 |
| HSA-MIR-548AM-5P | 99.94 | 71.24 | 3488 |
| HSA-MIR-548AP-5P | 99.94 | 71.14 | 3489 |
| HSA-MIR-548AQ-5P | 99.94 | 71.34 | 3426 |
| HSA-MIR-548AR-5P | 99.94 | 71.28 | 3515 |
| HSA-MIR-548AS-5P | 99.94 | 71.22 | 3482 |
| HSA-MIR-548AU-5P | 99.94 | 71.24 | 3488 |
| HSA-MIR-548AY-5P | 99.94 | 71.23 | 3502 |
| HSA-MIR-548B-5P | 99.94 | 71.23 | 3502 |
| HSA-MIR-548BB-5P | 99.94 | 71.27 | 3509 |
| HSA-MIR-548C-5P | 99.94 | 71.24 | 3488 |
| HSA-MIR-548D-5P | 99.94 | 71.23 | 3502 |
Cross-species orthologs
19 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | znf646 | ENSDARG00000061424 |
| danio_rerio | si:dkey-89b17.4 | ENSDARG00000075545 |
| danio_rerio | zgc:66472 | ENSDARG00000075916 |
| danio_rerio | si:ch211-148l7.4 | ENSDARG00000094469 |
| danio_rerio | znf576.1 | ENSDARG00000097819 |
| mus_musculus | Zfp764 | ENSMUSG00000045757 |
| mus_musculus | Zfp764l1 | ENSMUSG00000078580 |
| rattus_norvegicus | Zfp764 | ENSRNOG00000031003 |
| rattus_norvegicus | Zfp764l1 | ENSRNOG00000046480 |
| drosophila_melanogaster | az2 | FBGN0025185 |
| drosophila_melanogaster | CG2129 | FBGN0030008 |
| drosophila_melanogaster | CG1602 | FBGN0033186 |
| drosophila_melanogaster | CG18011 | FBGN0033491 |
| drosophila_melanogaster | CG12942 | FBGN0033569 |
| drosophila_melanogaster | indra | FBGN0035213 |
| drosophila_melanogaster | CG30020 | FBGN0050020 |
| drosophila_melanogaster | mld | FBGN0263490 |
| caenorhabditis_elegans | ztf-15 | WBGENE00011066 |
| caenorhabditis_elegans | WBGENE00015649 |
Paralogs (36): ZNF302 (ENSG00000089335), ZNF184 (ENSG00000096654), CTCF (ENSG00000102974), ZNF574 (ENSG00000105732), ZBTB24 (ENSG00000112365), ZNF142 (ENSG00000115568), CTCFL (ENSG00000124092), ZNF473 (ENSG00000142528), ZNF827 (ENSG00000151612), ZNF689 (ENSG00000156853), ZNF208 (ENSG00000160321), ZNF91 (ENSG00000167232), ZNF526 (ENSG00000167625), ZNF764 (ENSG00000169951), ZNF282 (ENSG00000170265), ZNF160 (ENSG00000170949), ZNF497 (ENSG00000174586), ZBTB34 (ENSG00000177125), ZNF771 (ENSG00000179965), ZNF48 (ENSG00000180035), ZNF594 (ENSG00000180626), ZBTB37 (ENSG00000185278), ZFP92 (ENSG00000189420), ZNF107 (ENSG00000196247), ZNF729 (ENSG00000196350), ZNF569 (ENSG00000196437), ZNF420 (ENSG00000197050), ZNF785 (ENSG00000197162), ZNF665 (ENSG00000197497), ZNF181 (ENSG00000197841), ZNF347 (ENSG00000197937), ZNF84 (ENSG00000198040), ZBTB48 (ENSG00000204859), ZNF845 (ENSG00000213799), ZNF99 (ENSG00000213973), ZNF688 (ENSG00000229809)
Protein
Protein identifiers
Zinc finger protein 747 — Q9BV97 (reviewed: Q9BV97)
All UniProt accessions (2): Q9BV97, A0A8I5KWK6
UniProt curated annotations — full annotation on UniProt →
Isoforms (3)
| UniProt ID | Names | Canonical? |
|---|---|---|
| Q9BV97-3 | 3 | yes |
| Q9BV97-1 | 1 | |
| Q9BV97-2 | 2 |
RefSeq proteins (4): NP_001291947, NP_001291948, NP_001291949, NP_076420 (=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR001909 | KRAB | Domain |
| IPR013087 | Znf_C2H2_type | Domain |
| IPR036051 | KRAB_dom_sf | Homologous_superfamily |
| IPR036236 | Znf_C2H2_sf | Homologous_superfamily |
Pfam: PF00096, PF01352
UniProt features (13 total): zinc finger region 4, splice variant 2, region of interest 2, compositionally biased region 2, chain 1, domain 1, sequence conflict 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q9BV97-F1 | 64.22 | 0.00 |
Function
Pathways and Gene Ontology
Reactome pathways
1 pathways
| ID | Pathway |
|---|---|
| R-HSA-212436 | Generic Transcription Pathway |
MSigDB gene sets: 69 (showing top):
CHANDRAN_METASTASIS_DN, AMIT_EGF_RESPONSE_120_HELA, chr16p11, YY1_01, GCCATNTTG_YY1_Q6, GOMF_SEQUENCE_SPECIFIC_DNA_BINDING, GOBP_NEGATIVE_REGULATION_OF_TRANSCRIPTION_BY_RNA_POLYMERASE_II, GOBP_NEGATIVE_REGULATION_OF_NUCLEOBASE_CONTAINING_COMPOUND_METABOLIC_PROCESS, GOMF_DNA_BINDING_TRANSCRIPTION_REPRESSOR_ACTIVITY, GOMF_TRANSCRIPTION_REGULATOR_ACTIVITY, BARX1_TARGET_GENES, CIITA_TARGET_GENES, E2F2_TARGET_GENES, ELF2_TARGET_GENES, FEV_TARGET_GENES
GO Biological Process (1): regulation of DNA-templated transcription (GO:0006355)
GO Molecular Function (3): zinc ion binding (GO:0008270), protein binding (GO:0005515), metal ion binding (GO:0046872)
GO Cellular Component (0):
Reactome top-level categories
Rollup of top-1 pathways:
| Category | Pathways |
|---|---|
| RNA Polymerase II Transcription | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| DNA-templated transcription | 1 |
| regulation of gene expression | 1 |
| regulation of RNA biosynthetic process | 1 |
| transition metal ion binding | 1 |
| binding | 1 |
| cation binding | 1 |
Protein interactions and networks
STRING
184 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| ZNF747 | DCLK3 | Q9C098 | 360 |
| ZNF747 | KAT8 | Q9H7Z6 | 330 |
| ZNF747 | ITGAL | P20701 | 300 |
| ZNF747 | BEST1 | O76090 | 252 |
| ZNF747 | BEST2 | Q8NFU1 | 251 |
| ZNF747 | WHAMM | Q8TF30 | 247 |
| ZNF747 | GPR153 | Q6NV75 | 242 |
| ZNF747 | VKORC1 | Q9BQB6 | 242 |
| ZNF747 | SETDB1 | Q15047 | 225 |
| ZNF747 | ITGAM | P11215 | 222 |
| ZNF747 | NRIP1 | P48552 | 220 |
| ZNF747 | ANKRD39 | Q53RE8 | 204 |
| ZNF747 | GABPA | Q06546 | 203 |
| ZNF747 | ZNF496 | Q96IT1 | 195 |
| ZNF747 | CRH | P06850 | 187 |
IntAct
33 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| ZNF747 | SUFU | psi-mi:“MI:0915”(physical association) | 0.890 |
| SUFU | ZNF747 | psi-mi:“MI:0915”(physical association) | 0.890 |
| ZNF747 | APPBP2 | psi-mi:“MI:0915”(physical association) | 0.560 |
| APPBP2 | ZNF747 | psi-mi:“MI:0915”(physical association) | 0.560 |
| INCA1 | ZNF747 | psi-mi:“MI:0915”(physical association) | 0.560 |
| ZNF707 | ZNF316 | psi-mi:“MI:0914”(association) | 0.530 |
| VWCE | ZNF316 | psi-mi:“MI:0914”(association) | 0.530 |
| PARP2 | ZNF747 | psi-mi:“MI:0557”(adp ribosylation reaction) | 0.440 |
| EFEMP1 | ZNF316 | psi-mi:“MI:0914”(association) | 0.350 |
| ZNF785 | CASK | psi-mi:“MI:0914”(association) | 0.350 |
| ZNF747 | TRIM28 | psi-mi:“MI:0914”(association) | 0.350 |
| CBX5 | ZNF568 | psi-mi:“MI:0914”(association) | 0.350 |
| PSME3 | C11orf98 | psi-mi:“MI:0914”(association) | 0.350 |
| RBSN | ZNF747 | psi-mi:“MI:0914”(association) | 0.350 |
| PIPSL | C1orf226 | psi-mi:“MI:0914”(association) | 0.350 |
| FBLN5 | ZNF320 | psi-mi:“MI:0914”(association) | 0.350 |
| NOTCH2 | ZNF320 | psi-mi:“MI:0914”(association) | 0.350 |
| LTBP2 | ZNF320 | psi-mi:“MI:0914”(association) | 0.350 |
| CBX3 | ZNF324 | psi-mi:“MI:0914”(association) | 0.350 |
| ZNF747 | PTGDS | psi-mi:“MI:0914”(association) | 0.350 |
| ZNF747 | CASP7 | psi-mi:“MI:0914”(association) | 0.350 |
BioGRID (54): ZNF747 (Two-hybrid), ZNF747 (Two-hybrid), ZNF747 (Affinity Capture-MS), ZNF747 (Reconstituted Complex), ZNF747 (Reconstituted Complex), ZNF747 (Affinity Capture-MS), ZNF747 (Affinity Capture-MS), ZNF747 (Affinity Capture-MS), SUFU (Affinity Capture-MS), MZB1 (Affinity Capture-MS), TRIM28 (Affinity Capture-MS), ZNF747 (Affinity Capture-MS), CYGB (Affinity Capture-MS), MRS2 (Affinity Capture-MS), IL18 (Affinity Capture-MS)
ESM2 similar proteins: A1YGK1, A2T7E6, A4D1S0, A9YTQ3, B1WBS3, I7HJS4, O43593, O43918, O60304, O75593, O95201, P0C6A0, P0C7X2, P97609, Q2MHN3, Q3B7M4, Q3SY56, Q3U133, Q58DK7, Q5JPB2, Q5SXI5, Q5T619, Q61645, Q6KAU7, Q6NUN9, Q6ZMS7, Q76NI1, Q7Z6P3, Q8BZ34, Q8BZW2, Q8CGW9, Q8IWN7, Q8IXT2, Q8IZ20, Q8NBB4, Q8NDX1, Q8NHY3, Q91X45, Q96PX9, Q99558
Diamond homologs: A0JPL0, A2A761, A3KN32, A3KN36, A6NFI3, A6NM28, A6QLU5, A6QPT6, A7MBI1, A8MTY0, B2RXC5, B4DU55, E9PYI1, O14978, O60765, O75467, O75820, O95780, P0C7X2, P0DKX0, P0DPD5, P10072, P15622, P16374, P17014, P17023, P17032, P17098, P51523, P51786, P52738, P52742, Q02975, Q06732, Q08DG8, Q08ER8, Q0VCB0, Q14590, Q14929, Q29RZ4
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
37 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 30 |
| Likely benign | 4 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
534 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 16:30533147:ATCTG:A | acceptor_gain | 1.0000 |
| 16:30533149:CTG:C | acceptor_gain | 1.0000 |
| 16:30534193:C:CA | donor_gain | 1.0000 |
| 16:30534445:TCTCA:T | donor_loss | 1.0000 |
| 16:30534446:CTCA:C | donor_loss | 1.0000 |
| 16:30534447:TCACC:T | donor_loss | 1.0000 |
| 16:30534448:CAC:C | donor_loss | 1.0000 |
| 16:30534449:A:AC | donor_gain | 1.0000 |
| 16:30534449:ACCGA:A | donor_loss | 1.0000 |
| 16:30534450:C:CA | donor_loss | 1.0000 |
| 16:30534450:C:CC | donor_gain | 1.0000 |
| 16:30533147:AT:A | acceptor_loss | 0.9900 |
| 16:30533148:TC:T | acceptor_loss | 0.9900 |
| 16:30533148:TCTG:T | acceptor_loss | 0.9900 |
| 16:30533148:TCTGC:T | acceptor_gain | 0.9900 |
| 16:30533149:C:CA | acceptor_loss | 0.9900 |
| 16:30533149:CTGC:C | acceptor_loss | 0.9900 |
| 16:30533149:CTGCT:C | acceptor_gain | 0.9900 |
| 16:30533150:T:G | acceptor_loss | 0.9900 |
| 16:30533150:TG:T | acceptor_gain | 0.9900 |
| 16:30533151:GCTG:G | acceptor_loss | 0.9900 |
| 16:30533152:C:CC | acceptor_gain | 0.9900 |
| 16:30533152:CTGAA:C | acceptor_loss | 0.9900 |
| 16:30533153:T:C | acceptor_loss | 0.9900 |
| 16:30534192:TCCA:T | donor_loss | 0.9900 |
| 16:30534193:CCA:C | donor_loss | 0.9900 |
| 16:30534194:CAC:C | donor_loss | 0.9900 |
| 16:30534195:A:AG | donor_loss | 0.9900 |
| 16:30534196:C:CT | donor_loss | 0.9900 |
| 16:30534220:TTCGC:T | donor_gain | 0.9900 |
AlphaMissense
2122 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 16:30534563:G:C | F39L | 0.991 |
| 16:30534563:G:T | F39L | 0.991 |
| 16:30534565:A:G | F39L | 0.991 |
| 16:30534527:C:A | W51C | 0.987 |
| 16:30534527:C:G | W51C | 0.987 |
| 16:30534482:C:A | M66I | 0.984 |
| 16:30534482:C:G | M66I | 0.984 |
| 16:30534482:C:T | M66I | 0.984 |
| 16:30534506:C:A | Q58H | 0.981 |
| 16:30534506:C:G | Q58H | 0.981 |
| 16:30534543:A:G | F46S | 0.980 |
| 16:30534542:G:C | F46L | 0.974 |
| 16:30534542:G:T | F46L | 0.974 |
| 16:30534544:A:G | F46L | 0.974 |
| 16:30534496:A:C | Y62D | 0.971 |
| 16:30534564:A:C | F39C | 0.970 |
| 16:30534564:A:G | F39S | 0.970 |
| 16:30534483:A:G | M66T | 0.966 |
| 16:30534496:A:T | Y62N | 0.953 |
| 16:30534477:T:A | E68V | 0.951 |
| 16:30534552:G:T | A43D | 0.946 |
| 16:30534529:A:G | W51R | 0.944 |
| 16:30534529:A:T | W51R | 0.944 |
| 16:30534503:C:A | R59S | 0.943 |
| 16:30534503:C:G | R59S | 0.943 |
| 16:30534487:C:A | V65L | 0.934 |
| 16:30534487:C:G | V65L | 0.934 |
| 16:30534530:C:A | E50D | 0.931 |
| 16:30534530:C:G | E50D | 0.931 |
| 16:30534495:T:G | Y62S | 0.924 |
dbSNP variants (sampled 300 via entrez): RS1000853654 (16:30535879 C>T), RS1000868120 (16:30530020 G>A,T), RS1000978717 (16:30530482 G>A), RS1001373111 (16:30536258 T>C), RS1002021295 (16:30536344 A>G,T), RS1002197056 (16:30530932 C>T), RS1002284318 (16:30533754 A>G), RS1002718125 (16:30531243 C>T), RS1002886018 (16:30534815 C>A,T), RS1003388485 (16:30533937 A>G), RS1003591169 (16:30531419 C>G,T), RS1004029602 (16:30534015 C>G,T), RS1004384339 (16:30530161 C>G,T), RS1004721978 (16:30534999 G>GA), RS1005295241 (16:30536772 C>T)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
1 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST90013407_107 | Liver enzyme levels (gamma-glutamyl transferase) | 3.000000e-28 |
EFO canonical traits (1, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0004532 | serum gamma-glutamyl transferase measurement |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
22 total (human), top 22 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Valproic Acid | affects cotreatment, decreases expression, increases expression | 3 |
| GSK-J4 | decreases expression | 1 |
| dicrotophos | increases expression | 1 |
| methylmercuric chloride | decreases expression | 1 |
| bisphenol A | increases expression, increases methylation | 1 |
| tris(1,3-dichloro-2-propyl)phosphate | decreases expression | 1 |
| ferrous chloride | decreases expression | 1 |
| 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | affects cotreatment, decreases expression | 1 |
| abrine | increases expression | 1 |
| dorsomorphin | affects cotreatment, decreases expression | 1 |
| 2,3,5-trichloro-6-phenyl-(1,4)benzoquinone | increases expression | 1 |
| Resveratrol | affects cotreatment, decreases expression | 1 |
| Sunitinib | decreases expression | 1 |
| Benzo(a)pyrene | decreases methylation | 1 |
| Cadmium | increases expression | 1 |
| Doxorubicin | decreases expression | 1 |
| Methotrexate | decreases expression | 1 |
| Plant Extracts | affects cotreatment, decreases expression | 1 |
| Smoke | decreases expression | 1 |
| Tobacco Smoke Pollution | increases expression | 1 |
| Urethane | decreases expression | 1 |
| Acrylamide | increases expression | 1 |
Cellosaurus cell lines
1 cell lines: 1 transformed cell line
First 10 cell lines (id-ordered, not curated):
| Cellosaurus | Name | Category | Sex |
|---|---|---|---|
| CVCL_XW80 | HEK293 eGFP-ZNF747 | Transformed cell line | Female |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.